Bao-Zhu Li

Dr. Bao-Zhu Li

Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2021 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
LLLing Li
Ling Li
YZYa-Li Zhang
Ya-Li Zhang
XLXing-Yu Liu
Xing-Yu Liu
XMXiang Meng
Xiang Meng
RZRong-Quan Zhao
Rong-Quan Zhao
TXTian Xing
Tian Xing
Periodontitis is a type of systemic immune inflammation that is caused by the complex infection of a variety of microorganisms in the subgingival plaque and the imbalance of the microbial ecological environment in the mouth. Periodontitis and chronic kidney disease (CKD) share many risk factors, such as obesity, smoking, and age. A growing body of data supports a strong correlation between periodontitis and kidney disease. Evidence supports the role of periodontal inflammation and elevated serum inflammatory mediators in renal atherosclerosis, renal deterioration, and end-stage renal disease (ESRD) development. Periodontitis is a risk factor for kidney disease. However, to our knowledge, there are few studies detailing the possible link between periodontitis and CKD. This review summarizes the possible mechanisms underlying periodontitis and CKD. More importantly, it highlights novel and potential pathogenic factors for CKD, including bacteria, pro-inflammatory mediators and oxidative stress. However, most research on the relationship between periodontitis and systemic disease has not determined causality, and these diseases are largely linked by bidirectional associations. Future research will focus on exploring these links to contribute to new treatments for CKD.

1 May 2020 in Archives of Oral Biology
Verified
Journal Article
Closed access
BLBao-Zhu Li
Bao-Zhu Li
HZHao-Yue Zhou
Hao-Yue Zhou
BGBiao Guo
Biao Guo
WCWen-Jun Chen
Wen-Jun Chen
JTJin-Hui Tao
Jin-Hui Tao
XMXiang Meng
Xiang Meng

22 May 2023 in Environmental Research
Verified
Journal Article
Closed access
RHRong-Gui Huang
Rong-Gui Huang
XLXian-Bao Li
Xian-Bao Li
YWYi-Yu Wang
Yi-Yu Wang
HWHong Wu
Hong Wu
KLKai-Di Li
Kai-Di Li
BLBao-Zhu Li
Bao-Zhu Li

27 August 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BLBao-Zhu Li
Bao-Zhu Li
NCNv-Wei Cao
Nv-Wei Cao
CRChun-Xia Ren
Chun-Xia Ren
XCXiu-Jie Chu
Xiu-Jie Chu
HZHao-Yue Zhou
Hao-Yue Zhou
BGBiao Guo
Biao Guo
At present, current didactic teaching delivery method help nursing students apply theory to clinical situations in an inefficient way. The flipped classroom (FC), a novel teaching mode emphasizing self-study and critical thinking, has generated interest in nursing education in China. However, there are a gap in the literature and no consistent outcomes of current studies which compared FC and lecture-based learning (LBL), and no systematic review has comprehensively compared theoretical scores as an affected outcome in FC versus LBL modes. In this review, we analyze flipped-learning nursing students’ scores, and aim to assess the efficacy and provide a deeper understanding of the FC in nursing education. Following the inclusion criteria, articles were obtained by searching PubMed, Embase and Chinese data, including the China National Knowledge Infrastructure, Wanfang Data, and VIP database until 3 January 2020. Data were extracted from eligible articles and quality was assessed. A meta-analysis was then performed using a random effects model with a standardized mean value (SMD) and a 95% confidence interval (CI).32 studies were included after reviewing 2,439 citations. All studies were randomized controlled trials (RCTs). The FC theoretical knowledge scores in FC were significantly positively affected compared to those of the traditional classroom (SMD = 1.33, 95% CI: 1.02–1.64; P < 0.001). In addition, 23 studies reported skill scores, indicating significant difference between the FC mode and LBL mode (SMD = 1.58, 95%CI: 1.23–1.93; P < 0.001). The results of this meta-analysis suggest that compared to the LBL teaching method, the FC mode dose significantly improve Chinese nursing students’ theoretical scores. However, the problems of heterogeneity and publication bias in this study need to be remedied high-quality future studies.

20 May 2022 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
HWHua Wang
Hua Wang
XLXian-Bao Li
Xian-Bao Li
XCXiu-Jie Chu
Xiu-Jie Chu
NCNv-Wei Cao
Nv-Wei Cao
HWHong Wu
Hong Wu
DYDong-Qing Ye
Dong-Qing Ye

2 February 2020 in Immunological Investigations
Verified
Journal Article
Closed access
HZHao-Yue Zhou
Hao-Yue Zhou
BGBiao Guo
Biao Guo
ELEniya Lufumpa
Eniya Lufumpa
XLXiao-Mei Li
Xiao-Mei Li
LCLi-Hong Chen
Li-Hong Chen
BLBao-Zhu Li
Bao-Zhu Li
Background: Biological agents are commonly used for the treatment of ulcerative colitis (UC). As new treatments, tofacitinib, and fecal microbiota transplantation (FMT) have demonstrated efficacy in treating UC. This network meta-analysis aims to determine the efficacy and safety of biological agents, tofacitinib, and FMT. Methods: A network meta-analysis was conducted by systematically searching the PubMed, Embase, and Cochrane Libraries. According to strict inclusion and exclusion criteria, we included randomized controlled trials (RCTs) of biological agents, tofacitinib, and FMT in UC. A random-effect model was chosen by the network meta-analysis and sensitivity analysis. Heterogeneity test and publication bias test were performed to determine the efficacy of treatments. Results: Data were extracted from 16 RCTs and we found that all treatments were more effective than the placebos. A total of 21 comparisons were made to determine efficiency. We found that infliximab, vedolizumab, and FMT performed better curative effect in terms of absolute effects and relative ranks. Furthermore, there was no statistical difference in the efficacy of biological agents, tofacitinib, and FMT. Moreover, no treatments were found to increase the occurrence of adverse events when compared with placebos, except infliximab. However, vedolizumab seemed to reduce the occurrence of adverse events compared with infliximab. Conclusion: Of the biological agents, vedolizumab and infliximab were the most effective, suggesting that biological agents are still a better choice. Nevertheless, tofacitinib and FMT may be promising alternatives with high efficacies. However, more safety and maintenance studies need to be conducted in future for the acquisition of more accurate results. Abbreviations: FMT: Fecal microbiota transplantation; UC: Ulcerative colitis; RCTs: Randomized controlled trials; IBD: Inflammatory bowel disease; CD: Crohn’s disease; IBS: Irritable bowel syndrome; CDI: Clostridium difficile infections; ITT: Intention-to-treat; RR: Relative risk; CI: Confidence interval; CrI: Credible intervals; IFX: Infliximab; ADA: Adalimumab; TFB: Tofacitinib; GLM: Golimumab; VDZ: Vedolizumab; PBO: Placebo; wk: week; F: Female; M: Male; AEs: Adverse events; SAEs: Serious adverse events; anti-TNF: Anti-tumor necrosis factors